The pharmacokinetics of YH1885 were evaluated after intravenous (iv) and oral administrations of the drug to rats and dogs. The reason for the low extent of bioavailability (F) of YH1885 after oral administration of the drug to rats and the absorption of the drug from various rat gastrointestinal (G
Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect
โ Scribed by Eun J. Kim; Sun-O. Kim; Dong H. Lee; Hong Lim; Myung G. Lee
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 121 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.264
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The purpose of this study was to investigate the causes for the differences observed in the pharmacokinetics of YJAโ20379โ8 in 16โweekโold spontaneously hypertensive rats (SHRs). To see if the hereditary characteristics of SHRs was the cause, 20 mg/kg of the drug was intravenously infus
## Abstract The pharmacokinetics of LโFMAUS after intravenous and oral administration (20, 50 and 100 mg/kg) to rats, gastrointestinal firstโpass effect of LโFMAUS (50 mg/kg) in rats, __in vitro__ stability of LโFMAUS, blood partition of LโFMAUS between plasma and blood cells of rat blood, and prot